ClinicalTrials.gg
CompletedNCT07802574Updated Oct 9, 2026

Effects of Interrupting Prolonged Sitting With Different Standing Intervals on Vascular Health in Women

An interventional study of Short Standing Interval and Continuous Standing Interval in Prolonged Sitting, Vascular Health and Sedentary Behavior, sponsored by King Saud University. Completed at 1 site in Saudi Arabia. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by King Saud University · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Apr 2026, registered Aug 2026).
Updated Oct 9, 2026Now CompletedPrimary completion moved+3 moreGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
Female
01

Study summary

The goal of this clinical trial is to examine the effects of interrupting prolonged sitting with different standing intervals on vascular health in healthy women aged 18-45 years. The main questions it aims to answer are:

Does interrupting prolonged sitting with short standing intervals (10 minutes every hour) improve blood pressure and pulse wave velocity more than prolonged continuous standing intervals (30 minutes every hour)? Does interrupting prolonged sitting with prolonged intermittent standing intervals (30 minutes every hour divided into three 10-minute standing bouts) improve blood pressure and pulse wave velocity more than prolonged continuous standing intervals (30 minutes every hour)?

The researcher will compare three different sitting interruption conditions to evaluate their effects on vascular health outcomes:

Standing for 10 minutes every hour. Continuous standing for 30 minutes every hour. Intermittent standing for 30 minutes every hour divided into three 10-minute standing bouts.

Participants will:

Attend three experimental sessions in random order separated by at least 7 days.

Complete 3 hours of sitting with different standing interruption protocols. Undergo measurements of blood pressure, pulse wave velocity, and heart rate before sitting and after each hour of the experiment.

Undergo height, weight, and body mass index measurements.

02

Conditions studied

  • Prolonged Sitting
  • Vascular Health
  • Sedentary Behavior

Browse trials for

03

In context

Sedentary Behavior

1,273 studies on the registry are indexed under Sedentary Behavior; 300 are open to participants now.

This study's enrollment of 21 is below the median of 60 across 1,076 interventional studies indexed under Sedentary Behavior.

Browse Sedentary Behavior studies →

Lead sponsor

King Saud University is the lead sponsor of 169 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

The criteria were revised on the registry on Oct 9, 2026. See what changed

Ages eligible
18 Years to 45 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female participants aged 18-45 years.
  • Healthy individuals with normal blood pressure levels (systolic blood pressure \<130 mmHg and diastolic blood pressure \<80 mmHg).
  • (BMI) less than 30 kg/m².
  • Ability to stand without support.
  • No history of cardiovascular disease or chronic diseases that may affect study outcomes.

Exclusion criteria

Exclusion Criteria:

  • Pregnancy or breastfeeding.
  • Back injuries preventing prolonged sitting.
  • Use of medications that may affect cardiovascular responses, including antihypertensive, antidiabetic, antidepressant, or hormonal medications.
  • Presence of chronic diseases or cardiovascular conditions affecting vascular health.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Experimental
    Short Standing Interval

    Participants will complete 3 hours of sitting interrupted with 10 minutes of standing every hour.

    Behavioral: Short Standing Interval

  • Experimental
    Continuous Standing Interval

    Participants will complete 3 hours of sitting interrupted with 30 continuous minutes of standing every hour.

    Behavioral: Continuous Standing Interval

  • Experimental
    Intermittent Standing Interval

    Participants will complete 3 hours of sitting interrupted with 30 minutes of standing every hour divided into three 10-minute standing bouts.

    Behavioral: Intermittent Standing Interval

Interventions

  • BehavioralShort Standing Interval

    Participants will interrupt prolonged sitting with 10 minutes of standing every hour during 3 hours of sitting.

  • BehavioralContinuous Standing Interval

    Participants will interrupt prolonged sitting with 30 continuous minutes of standing every hour during 3 hours of sitting.

  • BehavioralIntermittent Standing Interval

    Participants will interrupt prolonged sitting with 30 minutes of standing every hour divided into three 10-minute standing bouts during 3 hours of sitting.

06

What researchers measure

Primary outcomes

  1. Blood Pressure

    Systolic and diastolic blood pressure will be measured before sitting and after each hour during the experimental sessions.

    Time frame: Baseline, 1 hour, 2 hours, and 3 hours

  2. Pulse Wave Velocity

    Time frame: Baseline, 1 hour, 2 hours, and 3 hours

  3. Heart Rate

    Time frame: Baseline, 1 hour, 2 hours, and 3 hours

07

Study locations

1 site
  • King Saud University
    Riyadh, Saudi Arabia
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

1 registry update since Sep 25, 2026
Status
Recruiting→Completed
changed Oct 9, 2026
Primary completion
Sep 20, 2026→May 20, 2026 (actual)
Oct 9, 2026
Study completion
Oct 10, 2026→May 20, 2026 (actual)
Oct 9, 2026
Enrollment
24 (estimated)→21 (actual)
Oct 9, 2026
Eligibility
2 inclusion criteria edited, 3 added; 1 exclusion criterion edited, 2 added, 1 removed
What changed in the criteria
Inclusion criteria
  • AddedFemale participants aged 18-45 years.
  • EditedFemale participants aged 18-45 years. Healthy individuals with normal blood pressure levels (systolic blood pressure <130 mmHg and diastolic blood pressure <80 mmHg).
  • AddedBody mass index (BMI) less than 30 kg/m².
  • AddedAbility to stand without support.
  • EditedBody mass index (BMI) less than 30 kg/m². Ability to stand without support. No history of cardiovascular disease or chronic diseases that may affect study outcomes.
Exclusion criteria
  • AddedPregnancy or breastfeeding.
  • AddedBack injuries preventing prolonged sitting.
  • EditedPregnancy or breastfeeding. Back injuries preventing prolonged sitting. Use of medications that may affect cardiovascular responses, including antihypertensive, antidiabetic, antidepressant, or hormonal medications.
  • Removed-
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Recruiting→Completed
    Primary completion Sep 20, 2026→May 20, 2026 (now actual)
    Study completion Oct 10, 2026→May 20, 2026 (now actual)
    Enrollment 24 (estimated)→21 (actual)
    Eligibility 2 inclusion criteria edited, 3 added; 1 exclusion criterion edited, 2 added, 1 removed
    What changed in the criteria
    Inclusion criteria
    • AddedFemale participants aged 18-45 years.
    • EditedFemale participants aged 18-45 years. Healthy individuals with normal blood pressure levels (systolic blood pressure <130 mmHg and diastolic blood pressure <80 mmHg).
    • AddedBody mass index (BMI) less than 30 kg/m².
    • AddedAbility to stand without support.
    • EditedBody mass index (BMI) less than 30 kg/m². Ability to stand without support. No history of cardiovascular disease or chronic diseases that may affect study outcomes.
    Exclusion criteria
    • AddedPregnancy or breastfeeding.
    • AddedBack injuries preventing prolonged sitting.
    • EditedPregnancy or breastfeeding. Back injuries preventing prolonged sitting. Use of medications that may affect cardiovascular responses, including antihypertensive, antidiabetic, antidepressant, or hormonal medications.
    • Removed-
    + 4 other changes: verification date, responsible party, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07802574
Responsible party
Bushra Khalid Alharbi (Principal Investigator, King Saud University) — Principal investigator
First posted
Sep 3, 2026
Start date
Apr 2, 2026
Primary completion
May 20, 2026
Completion
May 20, 2026
Last update
Oct 9, 2026

Study contacts

Abdullah B Alansare, PhD
study chair · King Saud University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion